Tag Archives: Pulmonary

Prophylactic Azithromycin Beneficial in Idiopathic Pulmonary Fibrosis

December 14, 2018 Share this content: The number of hospital admissions and antibiotics prescribed dropped in participants who took prophylactic azithromycin. Prophylactic azithromycin may reduce hospital stays and the need for rescue antibiotics in patients with idiopathic pulmonary fibrosis (IPF), according to a retrospective study published in the European Respiratory Journal. Researchers analyzed the use of… Read More »

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD)

FDA Approves Yupelri (revefenacin) for Chronic Obstructive Pulmonary Disease (COPD) Print this page DUBLIN, Ireland, HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2018 /PRNewswire/ — Theravance Biopharma, Inc. (NASDAQ: TBPH) (“Theravance Biopharma”) and Mylan N.V. (NASDAQ: MYL) (“Mylan”) today announced that the U.S. Food and Drug Administration (FDA) has approved the  New Drug Application (NDA) for… Read More »